The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
  • World Expo 2030
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
The Korea Times
amn_close.png
amn_bl.png
National
  • Politics
  • Foreign Affairs
  • Multicultural Community
  • Defense
  • Environment & Animals
  • Law & Crime
  • Society
  • Health & Science
amn_bl.png
Business
  • Tech
  • Bio
  • Companies
  • World Expo 2030
amn_bl.png
Finance
  • Companies
  • Economy
  • Markets
  • Cryptocurrency
amn_bl.png
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to President
  • Letter to the Editor
amn_bl.png
Lifestyle
  • Travel & Food
  • Trends
  • People & Events
  • Books
  • Around Town
  • Fortune Telling
amn_bl.png
Entertainment & Arts
  • K-pop
  • Films
  • Shows & Dramas
  • Music
  • Theater & Others
amn_bl.png
Sports
amn_bl.png
World
  • SCMP
  • Asia
amn_bl.png
Video
  • Korean Storytellers
  • POPKORN
  • Culture
  • People
  • News
amn_bl.png
Photos
  • Photo News
  • Darkroom
amn_NK.png amn_DR.png amn_LK.png amn_LE.png
  • bt_fb_on_2022.svgbt_fb_over_2022.svg
  • bt_twitter_on_2022.svgbt_twitter_over_2022.svg
  • bt_youtube_on_2022.svgbt_youtube_over_2022.svg
  • bt_instagram_on_2022.svgbt_instagram_over_2022.svg
  • Login
  • Register
  • Login
  • Register
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
  • 1

    Hybe's new boy group Boynextdoor aims to be 'one and only' presence in K-pop

  • 3

    Brave Girls to restart activities under new name

  • 5

    Rapper Mino attends sister's wedding in U.S. amid military service

  • 7

    Running convenience stores becomes popular among people in 20s, 30s

  • 9

    Actors' off-screen chemistry enthralls fans

  • 11

    Sluggish exports behind weak Korean won

  • 13

    Naver suffers shrinking online search market share

  • 15

    Doctors, pharmacists to receive 30% bonus for offering telemedicine service

  • 17

    'Elemental' director on bringing his personal story of immigration to cinema

  • 19

    BTS' J-Hope to work as drill instructor at Army boot camp: sources

  • 2

    Seoul city erroneously sends emergency alert after NK launch

  • 4

    NK's attempt to launch 1st spy satellite fails after 'abnormal' flight: S. Korean military

  • 6

    Korea to ease immigration rules to attract more medical tourists

  • 8

    Big businesses face growing union pressure to extend retirement age

  • 10

    Seoul city takes flak for emergency text alert on NK's rocket launch

  • 12

    Anti-corruption watchdog set to investigate crypto assets of lawmakers

  • 14

    Seoul resident clashes with authorities for raising dogs to nab 'North Korean spies'

  • 16

    Pyongyang may have delayed spy satellite launch due to technical issues

  • 18

    NATIONALKorea likely to face pressure over imports of Fukushima seafood

  • 20

    Directors thrive on streaming platforms amid sluggish film industry

Close scrollclosebutton

Close for 24 hours

Open
  • The Korea Times
  • search
  • all menu
  • Login
  • Subscribe
  • Photos
  • Video
  • World
  • Sports
  • Opinion
  • Entertainment & Art
  • Lifestyle
  • Finance
  • Business
  • National
  • North Korea
Business
Bio
  • Tech
  • Bio
  • Companies
  • World Expo 2030
Thu, June 1, 2023 | 11:12
Korean biotech firms show off capabilities in Europe
Korean biotech firms show off capabilities in Europe
HLB, Celltrion, NeoImmuneTech and other Korean biotech companies confirmed their competitiveness in Europe as they showcased their new drug development capabilities at the European Society for Medical Oncology (ESMO) Congress, an annual medical oncology fair to share the latest developments in cancer research, they said Tuesday. This year's ESMO Congress was held in Paris for...
Baek Byung-yeul | 2022-09-13 16:46
HLB's liver cancer treatment shows longest overall survival
HLB's liver cancer treatment shows longest overall survival
Local biotech company HLB said its liver cancer treatment candidate Rivoceranib showed over 22 months of overall survival in its Phase 3 clinical trials, the longest in any liver cancer treatment, the company said, Thursday. The company said it plans to hold a meeting with the U.S. Food and Drug Administration (FDA) to apply for approval for new drugs, given the effectiveness...
Baek Byung-yeul | 2022-09-08 14:20
Celltrion receives approval to sell anticancer biosimilar Vegzelma in Europe
Celltrion receives approval to sell anticancer biosimilar Vegzelma in Europe
Korean biopharmaceutical firm Celltrion said Friday it has received an approval to sell its anticancer biosimilar Vegzelma in Europe.
2022-08-19 15:52
Samsung Biologics, C&T invest in US biotech firm Senda Biosciences
Samsung Biologics, C&T invest in US biotech firm Senda Biosciences
An investment fund created by Samsung Biologics and Samsung C&T invested $15 million into U.S.-based biotechnology company Senda Biosciences as part of their efforts to foster core technology required to develop next-generation biopharmaceuticals, Samsung Biologics said on Wednesday. Samsung Biologics said the Life Science Fund, jointly formed by itself and Samsung C&T, decid...
Baek Byung-yeul | 2022-08-17 16:16
Yoon promises to foster bio-health industry
Yoon promises to foster bio-health industry
President Yoon Suk-yeol vowed Wednesday to foster the bio-health industry into a key national strategic industry as he met with health experts at a medical research facility.
2022-07-27 14:13
Daesang to set up joint venture with China Sinopharm International
Daesang to set up joint venture with China Sinopharm International
Daesang Life Science, a Korean manufacturer of health functional foods, said Wednesday it has inked a letter of intent with China Sinopharm International to set up a joint venture in a bid to make forays into the Chinese market.
2022-07-27 14:13
Matica Bio aims to join global top 5 cell & gene therapy producers by 2030
Matica Bio aims to join global top 5 cell & gene therapy producers by 2030
Matica Biotechnology, a U.S. subsidiary of CHA Biotech, revealed its goal to join the global top five manufacturers of cell and gene therapy and generate sales of over 1 trillion won ($762.8 million) by 2030, its CEO said Thursday. “The global cell and gene therapy's CDMO (contract development and manufacturing organization) market is expected to grow by more than 20 percent ...
Baek Byung-yeul | 2022-07-21 16:10
Korean disease institute, Moderna agree to collaborate in SFTS mRNA vaccine development
Korean disease institute, Moderna agree to collaborate in SFTS mRNA vaccine development
Korea's state-run National Institute of Infectious Diseases (NIID) said Wednesday it has reached an agreement with Moderna, a U.S. biotech company, to cooperate in the development of a messenger RNA (mRNA) vaccine candidate for severe fever and thrombocytopenia syndrome (SFTS).
2022-07-20 13:18
Split from GSK, Haleon seeks to solidify consumer healthcare leadership
Split from GSK, Haleon seeks to solidify consumer healthcare leadership
Consumer healthcare company Haleon was officially launched on Monday (U.K. time) after completing its spinoff from GSK, its Korean unit said Tuesday. Haleon is a global leading company in the consumer healthcare markets of 170 countries, selling numerous well-known brands such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, Parodontax and Centrum.
Baek Byung-yeul | 2022-07-19 16:34
Moderna says committed to making Omicron-adaptive vaccine candidate available in Aug.
Moderna says committed to making Omicron-adaptive vaccine candidate available in Aug.
Moderna, a U.S. biotech company specializing in messenger RNA (mRNA) coronavirus vaccines, is committed to making its new bivalent vaccine candidate available next month, which reportedly demonstrates a superior antibody response against Omicron variants.
2022-07-19 15:29
1234 5 6789
Top 10 Stories
1Seoul City takes flak for bungled emergency text alert on NK's rocket launch Seoul City takes flak for bungled emergency text alert on NK's rocket launch
2Rude cabbies in Seoul face stricter penaltiesRude cabbies in Seoul face stricter penalties
3[INTERVIEW] Asia expected to be key driver of ESG growth: Deloitte ESG Partner INTERVIEWAsia expected to be key driver of ESG growth: Deloitte ESG Partner
4North Korea's spy satellite launch fails as rocket falls into sea North Korea's spy satellite launch fails as rocket falls into sea
5Retailers adopt generative AI to offer personalized products, services Retailers adopt generative AI to offer personalized products, services
6Committee calls for lowering requirements for foreigners to teach English online Committee calls for lowering requirements for foreigners to teach English online
7Chinese account for 54% of foreign-owned homes in Korea Chinese account for 54% of foreign-owned homes in Korea
8AMCHAM stresses S. Korea-US ties after NK fires 'space launch vehicle' AMCHAM stresses S. Korea-US ties after NK fires 'space launch vehicle'
9LS chairman appears in YouTube commercial LS chairman appears in YouTube commercial
10Mercedes-Benz Korea appoints new CEO Mercedes-Benz Korea appoints new CEO
DARKROOM
  • Turkey-Syria earthquake

    Turkey-Syria earthquake

  • Nepal plane crash

    Nepal plane crash

  • Brazil capital uprising

    Brazil capital uprising

  • Happy New Year 2023

    Happy New Year 2023

  • World Cup 2022 Final - Argentina vs France

    World Cup 2022 Final - Argentina vs France

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.
  • About Us
  • Introduction
  • History
  • Contact Us
  • Products & Services
  • Subscribe
  • E-paper
  • RSS Service
  • Content Sales
  • Site Map
  • Policy
  • Code of Ethics
  • Ombudsman
  • Privacy Statement
  • Terms of Service
  • Copyright Policy
  • Family Site
  • Hankook Ilbo
  • Dongwha Group